(S,R,S)-AHPC-C2-NH2 dihydrochloride is a high-purity E3 ligase ligand-linker conjugate designed specifically for use in PROTAC (Proteolysis Targeting Chimera) drug development. This bifunctional compound features the (S,R,S)-AHPC (aryl hydrocarbon receptor-binding protein complex) moiety, which selectively recruits the CRBN (Cereblon) E3 ubiquitin ligase. The C2 linker and terminal amine group provide optimal flexibility and compatibility, enabling efficient conjugation to target protein ligands. As a crucial building block for PROTAC design, (S,R,S)-AHPC-C2-NH2 dihydrochloride facilitates targeted protein degradation by driving ubiquitination and proteasomal clearance of disease-associated proteins. Ideal for research in oncology, neurodegeneration, and other therapeutic areas, this ligand-linker intermediate empowers scientists to accelerate the development of next-generation protein degradation therapeutics. Category: E3 Ligase Ligand-Linker Conjugate.
Structure of 2341796-73-2
* For research and manufacturing use only. Not for human or clinical use.
| Size | Price | Stock | Quantity |
|---|---|---|---|
| -- | $-- | In stock |
Looking for different specifications? Click to request a custom quote!
Capabilities & Facilities
Popular Publications Citing BOC Sciences Products
Background Introduction
(S,R,S)-AHPC-C2-NH2 dihydrochloride is a versatile E3 ligase ligand-linker conjugate designed specifically for PROTAC (Proteolysis Targeting Chimera) technology. By incorporating the AHPC (aryl hydroxyproline carboxamide) moiety, this molecule efficiently recruits the von Hippel-Lindau (VHL) E3 ubiquitin ligase, enabling targeted protein degradation. As a functionalized warhead with a reactive amine group and a dihydrochloride salt for enhanced solubility, (S,R,S)-AHPC-C2-NH2 serves as an essential building block in next-generation drug discovery research and targeted protein degradation applications.
Mechanism
The mechanism of (S,R,S)-AHPC-C2-NH2 dihydrochloride centers on its role as the E3 ligase-binding arm in bifunctional PROTAC molecules. The AHPC motif selectively binds to the VHL E3 ligase complex, while the C2-linked primary amine provides a handle for conjugating target protein ligands via amide bond formation. Upon cellular entry, PROTACs constructed with (S,R,S)-AHPC-C2-NH2 bring the E3 ligase and target protein into proximity. This facilitates ubiquitination and proteasomal degradation of the target, driving potent and selective protein knockdown.
Applications
(S,R,S)-AHPC-C2-NH2 dihydrochloride is widely used in the custom synthesis of PROTAC molecules for targeted protein degradation studies. Its applications span early-stage drug discovery, functional genomics, and validation of novel drug targets. Scientists use this ligand-linker conjugate to streamline the development of PROTAC libraries against disease-associated proteins, enabling rapid screening and structure-activity relationship (SAR) exploration. Its reliable E3 ligase recruitment makes it highly valuable for both academic research and pharmaceutical development in the emerging field of targeted protein degradation.
* Our calculator is based on the following equation:
Concentration (start) x Volume (start) = Concentration (final) x Volume (final)
It is commonly abbreviated as: C1V1 = C2V2
Please contact us with any specific requirements and we will get back to you as soon as possible.